Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPOX | P50336 | 15/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.52 |
| ▸ | PGK1 | P00558 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Simazine SCHEMBL7579114 | 0.95 | PPOX (0.52) | PPOXKMT2AMEN1TDP1NR1I2 | |
| Terbuthylazine SCHEMBL7583558 | 0.91 | PPOX (0.49) | PPOXKMT2AMEN1TDP1NR1I2 | |
| Atrazine SCHEMBL7577621 | 0.90 | PPOX (0.43) | PPOXKMT2AMEN1TDP1NR1I2 | |
| Cyanazine SCHEMBL7587830 | 0.89 | PPOX (0.46) | PPOXKMT2AMEN1TDP1NR1I2 | |
| Oxadiazon SCHEMBL7578893 | 0.88 | PPOX (0.69) | PPOXKMT2AMEN1TDP1NR1I2 | |
| Atrazine SCHEMBL7585044 | 0.88 | PPOX (0.41) | PPOXKMT2AMEN1TDP1NR1I2 | |
| Atrazine SCHEMBL7583615 | 0.87 | PPOX (0.40) | PPOXKMT2AMEN1TDP1NR1I2 | |
| Simazine SCHEMBL7585337 | 0.86 | PPOX (0.42) | PPOXKMT2AMEN1TDP1NR1I2 | |
| Oxadiazon SCHEMBL7586919 | 0.84 | PPOX (0.74) | PPOXKMT2AMEN1TDP1NR1I2 | |
| Terbutryne SCHEMBL7583162 | 0.84 | PPOX (0.46) | PPOXKMT2AMEN1TDP1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | PPOX 1/4885KMT2A 2099/4885MEN1 4274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.